Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
CAI
$25.02
-2.40%
CAI
· Caris Life Sciences, Inc.
Market Cap
$7.24B
Shares
282.60M
All earnings calls
Earnings call · FY2025 Q2
Caris Life Sciences, Inc. (CAI) Q2 2025 Earnings Call
Forward guidance
2 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$181.40M
+81.3% YoY
Diluted EPS
-$7.97
Net income
-$71.79M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 12, 2025.
| Metric | Period | Guided | Basis | Actual |
|---|---|---|---|---|
|
Full year 2025 revenue
Initiated
full year 2025
|
$675M – $685M | — | $812.03M above | |
|
Clinical therapy selection volume
Initiated
full year 2025
|
19% – 21% | — | — |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 12, 2025 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 12, 2025 · complete as-filed document